Baza je ažurirana 20.11.2024. 

zaključno sa NN 109/24

EU 2024/2679

PRESTAO VAŽITI ALI VIDI OVDJE!
NN 6/2022 (14.1.2022.), Odluka o izmjenama i dopunama Odluke o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje

 

Hrvatski zavod za zdravstveno osiguranje

57

Na osnovi članka 20. stavka 7. Zakona o obveznom zdravstvenom osiguranju (»Narodne novine«, broj 80/13., 137/13. i 98/19.) i članka 26. točke 10. Statuta Hrvatskog zavoda za zdravstveno osiguranje (»Narodne novine«, broj 18/09., 33/10., 08/11., 18/13., 1/14., 83/15. i 108/21.) Upravno vijeće Hrvatskog zavoda za zdravstveno osiguranje na 43. sjednici održanoj 11. siječnja 2022. godine, uz prethodno pribavljeno mišljenje Hrvatske liječničke komore, donijelo je

ODLUKU

O IZMJENAMA I DOPUNAMA ODLUKE O UTVRĐIVANJU OSNOVNE LISTE LIJEKOVA HRVATSKOG ZAVODA ZA ZDRAVSTVENO OSIGURANJE

Članak 1.

U Odluci o utvrđivanju Osnovne liste lijekova Hrvatskog zavoda za zdravstveno osiguranje (»Narodne novine«, broj 135/21.), u Osnovnoj listi lijekova iz članka 2. stavka 5. pod šiframa anatomsko-terapijsko-kemijske (ATK) klasifikacije lijekova Svjetske zdravstvene organizacije mijenjaju se sljedeći podaci:

»

 

Šifra ATK

Oznaka

Nezaštićeno ime lijeka

DDD i jed. mj.

Cijena za DDD

Cijena za DDD (s PDV-om)

Način primjene

Nositelj odobrenja

Proizvođač

Zaštićeno ime lijeka

Oblik, jačina i pakiranje lijeka

Cijena jed. oblika

Cijena jed. oblika (s PDV-om)

Cijena orig. pakiranja

Cijena orig. pakiranja (s PDV-om)

R/RS

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

B02BB01 071

DS

fibrinogen

5 g

14.690,00

15.424,50

P

Jana Pharm d.o.o.

Octapharma Pharmazeutika Produktionsges .m.b.H., Octapharma AB

Fibryga

praš. i otap. za otop. za inj./inf., stak. boč. 1x1 g

2.938,00

3.084,90

2.938,00

3.084,90

 

B02BD04 095

DS

rekombinantni čimbenik IX (nonakog alfa)NB205

 

 

 

P

Pfizer Europe MA EEIG

Wyeth Farma S.A.

BeneFIX

praš. i otap. za otop. za inj., boč. stakl. 1x250 i.j.

891,19

935,75

891,19

935,75

 

B02BD04 096

DS

rekombinantni čimbenik IX (nonakog alfa)NB205

 

 

 

P

Pfizer Europe MA EEIG

Wyeth Farma S.A.

BeneFIX

praš. i otap. za otop. za inj., boč. stakl. 1x500 i.j.

1.782,38

1.871,50

1.782,38

1.871,50

 

B02BD04 097

DS

rekombinantni čimbenik IX (nonakog alfa)NB205

 

 

 

P

Pfizer Europe MA EEIG

Wyeth Farma S.A.

BeneFIX

praš. i otap. za otop. za inj., boč. stakl. 1x1.000 i.j.

3.564,76

3.743,00

3.564,76

3.743,00

 

B02BD04 098

DS

rekombinantni čimbenik IX (nonakog alfa)NB205

 

 

 

P

Pfizer Europe MA EEIG

Wyeth Farma S.A.

BeneFIX

praš. i otap. za otop. za inj., boč. stakl. 1x2.000 i.j.

7.129,52

7.486,00

7.129,52

7.486,00

 

B05AA01 064

DS

ljudski albumin 20%NB502

 

 

 

P

Jana Pharm d.o.o.

Octapharma

Albunorm 20% (non HR)

otop. za inf., boč. stakl. 1x100 ml

408,59

429,02

408,59

429,02

 

C01CA07 061

DS

dobutamin

0,5 g

58,00

60,90

P

Panpharma

Panpharma GmbH

Dobutamin Panpharma

konc. za otop. za inf., boč. stakl. 10x250 mg/20 ml

29,00

30,45

290,00

304,50

 

D06AX09 461

 

mupirocin

 

 

 

L

GlaxoSmithKline Trading Services Limited

Glaxo Operations UK Limited, GlaxoSmithKline Pharmaceuticals S.A.

Bactroban

mast 1x15 g (20 mg/g)

26,13

27,44

26,13

27,44

R

H05AA02 001

RL

teriparatid

20 mcg

54,67

57,40

P

PLIVA HRVATSKA d.o.o.

Pliva Hrvatska d.o.o., Teva Pharma B.V.

Teriparatid Pliva

otop. za inj., brizg. napunj. 1x600 mcg/2,4 ml (250 mcg/ml)

1.640,11

1.722,12

1.640,11

1.722,12

RSRH07

J01CR02 171

 

amoksicilin + klavulanska kiselina

1.5 g

4,04

4,24

O

GlaxoSmithKline Trading Services Limited

SmithKline Beecham Pharmaceuticals, Glaxo Wellcome Production

Augmentin

tbl. film obl. 14x1 g (875 mg +125 mg)

2,36

2,48

33,00

34,65

RRJ04

J01CR02 273

 

amoksicilin + klavulanska kiselina

1.5 g

6,01

6,31

O

GlaxoSmithKline Trading Services Limited

SmithKline Beecham Pharmaceuticals, Glaxo Wellcome Production

Augmentin

susp. 70 ml(400 mg +57 mg)/5 ml

22,45

23,57

22,45

23,57

RRJ04

J01CR05 041

DS

piperacilin + tazobaktamNJ101

14 g

216,38

227,20

P

Sandoz d.o.o.

Sandoz

Piperacilin/tazobaktam Sandoz

praš. za otop. za inf., boč. 10x(4,0 g+0,5 g)/100ml

61,82

64,91

618,23

649,14

 

J01MA12 021

DS

levofloksacinNJ105

0,5 g

132,53

139,16

P

Sandoz d.o.o.

Lek Pharmaceuticals d.d.

Levofloksacin Sandoz

otop. za inf., vreć. 1x100 ml (5 mg/ml)

132,53

139,16

132,53

139,16

 

J05AB06 071

KS

ganciklovir

0,5 g

225,94

237,24

P

Cheplapharm Arzneimittel GmbH

Cheplapharm Arzneimittel GmbH, Prestige Promotion Verkaufsförderung & Werbeservice GmbH

Cymevene

boč. 1x500 mg/10 ml

225,94

237,24

225,94

237,24

 

J05AH01 771

DS

zanamivirNJ506

20 mg

22,99

24,14

I

GlaxoSmithKline Trading Services Limited

Glaxo Wellcome Production, Glaxo Operations UK Limited

Relenza

praš. za inhal. 20x5 mg (5 rotadisk blist. po 4 doze +diskhaler)

5,75

6,03

114,93

120,68

 

J05AP54 161

DS

elbasvir + grazoprevirNJ711

 

 

 

O

Merck Sharp & Dohme B.V.

Schering-Plough Labo N.V.

Zepatier

tbl. film obl. 28x(50 mg+100 mg)

2.488,60

2.613,03

69.680,89

73.164,93

 

J05AP54 162

DS

elbasvir + grazoprevirNJ711

 

 

 

O

Merck Sharp & Dohme B.V.

Schering-Plough Labo N.V.

Zepatier

tbl. film obl. 28x(50 mg+100 mg)

2.488,60

2.613,03

69.680,89

73.164,93

 

J06BA01 061

 

imunoglobulin, ljudskiNJ708

 

 

 

P

Jana Pharm d.o.o.

Octapharma AB

Gammanorm

otop. za inj., boč. 1x10 ml (165 mg/ml)

727,77

764,16

727,77

764,16

RSRJ53

J06BD01 051

DS

palivizumabNJ605

 

 

 

P

 

 

 

 

 

 

 

 

 

J06BD01 084

DS

palivizumabNJ605

 

 

 

P

AstraZeneca AB

AbbVie S.r.l.

Synagis

otop. za inj., boč. stakl. 1x1 ml (100 mg/mL)

6.252,88

6.565,52

6.252,88

6.565,52

 

J07BC01 074

DS

cjepivo protiv hepatitisa B

 

 

 

P

GlaxoSmithKline Biologicals S.A.

GlaxoSmithKline Biologicals S.A.

Engerix -B dosis adulta

1x20 mcg/1 ml susp. za inj. u napunj. štrc.

78,87

82,81

78,87

82,81

 

J07BC01 075

DS

cjepivo protiv hepatitisa B

 

 

 

P

GlaxoSmithKline Biologicals S.A.

GlaxoSmithKline Biologicals S.A.

Engerix -B dosis pediatrica

1x10 mcg/0,5 ml susp. za inj. u napunj. štrc.

48,00

50,40

48,00

50,40

 

J07BD52 061

PR

cjepivo protiv morbila-parotitisa-rubele (MO-PA-RU)

 

 

 

P

GlaxoSmithKline Biologicals S.A.

GlaxoSmithKline Biologicals S.A.

Priorix

cjepivo kombinirano, liof., boč. 1x1 doza +štrc. napunj. s 0,5 ml vode za injekcije+2 igle sa zaštitom

66,32

69,64

66,32

69,64

 

J07CA06 071

PR

cjepivo protiv difterije, tetanusa-DT, pertusisa-(acelularno), poliomijelitisa-IPV (inaktivirano), adsorbirano i Haemophilus influenzae tip b (konjugirano)NJ707

 

 

 

P

GlaxoSmithKline Biologicals S.A.

GlaxoSmithKline Biologicals S.A.

Infanrix-IPV+Hib

štrc. stakl. 1x0,5 ml +1 stakl.boč. s praškom +2 igle sa zaštitom, susp.

141,29

148,35

141,29

148,35

 

L01EA01 101

DS

imatinibNL115

400 mg

218,28

229,19

O

PLIVA HRVATSKA d.o.o.

Pliva Hrvatska d.o.o.

Plivatinib

tbl. film obl. 60x100 mg

54,57

57,30

3.274,20

3.437,91

 

L01EA01 102

DS

imatinibNL115

400 mg

209,51

219,99

O

PLIVA HRVATSKA d.o.o.

Pliva Hrvatska d.o.o.

Plivatinib

tbl. film obl. 30x400 mg

209,51

219,99

6.285,30

6.599,57

 

L01EA01 121

DS

imatinibNL458

400 mg

171,23

179,80

O

Sandoz d.o.o.

Lek Pharmaceuticals d.d., Salutas Pharma GmbH

Imatinib Sandoz

tbl. film obl. 60x100 mg

42,81

44,95

2.568,51

2.696,94

 

L01EA01 122

DS

imatinibNL458

400 mg

169,86

178,35

O

Sandoz d.o.o.

Lek Pharmaceuticals d.d., Salutas Pharma GmbH

Imatinib Sandoz

tbl. film obl. 30x400 mg

169,86

178,35

5.095,71

5.350,50

 

L01EA01 135

DS

imatinib NL115

400 mg

218,28

229,19

O

KRKA-FARMA d.o.o.

KRKA-FARMA d.o.o., Krka d.d.

Meaxin

tbl. film obl. 60x100 mg

54,57

57,30

3.274,20

3.437,91

 

L01EA01 136

DS

imatinib NL115

400 mg

222,05

233,16

O

KRKA-FARMA d.o.o.

KRKA-FARMA d.o.o., Krka d.d.

Meaxin

tbl. film obl. 90x100 mg

55,51

58,29

4.996,20

5.246,01

 

L01EA01 137

DS

imatinibNL115

400 mg

209,51

219,99

O

KRKA-FARMA d.o.o.

KRKA-FARMA d.o.o., Krka d.d.

Meaxin

tbl. film obl. 30x400 mg

209,51

219,99

6.285,30

6.599,57

 

L01EA01 138

DS

imatinib NL115

400 mg

204,52

214,75

O

KRKA-FARMA d.o.o.

KRKA-FARMA d.o.o., Krka d.d.

Meaxin

tbl. film obl. 60x400 mg

204,52

214,75

12.271,20

12.884,76

 

L01EA01 141

DS

imatinibNL115

400 mg

162,67

170,81

O

Alkaloid-INT d.o.o.

Alkaloid - INT d.o.o.

Imatinib Alkaloid-INT

tbl. film obl. 60x100 mg

40,67

42,70

2.440,08

2.562,08

 

L01EA01 142

DS

imatinibNL115

400 mg

161,36

169,43

O

Alkaloid-INT d.o.o.

Alkaloid - INT d.o.o.

Imatinib Alkaloid-INT

tbl. film obl. 30x400 mg

161,36

169,43

4.840,92

5.082,97

 

L01EA01 161

DS

imatinibNL115

400 mg

218,28

229,19

O

Zentiva k.s.

Remedica Ltd., Pharmadox Healthcare Ltd.

Imakrebin

tbl. film obl. 60x100 mg

54,57

57,30

3.274,20

3.437,91

 

L01EA01 162

DS

imatinibNL115

400 mg

209,51

219,99

O

Zentiva k.s.

Remedica Ltd., Pharmadox Healthcare Ltd.

Imakrebin

tbl. film obl. 30x400 mg

209,51

219,99

6.285,30

6.599,57

 

L01EA01 173

DS

imatinibNL115

400 mg

209,51

219,99

O

Novartis Europharm Limited Irska

Novartis Pharma

Glivec

tbl. film obl. 30x400 mg

209,51

219,99

6.285,30

6.599,57

 

L01EA01 193

DS

imatinibNL115

400 mg

190,26

199,77

O

Accord Healthcare S.L.U.

Accord Healthcare Limited

Imatinib Accord

tbl. film obl. 60x100 mg

47,57

49,94

2.853,90

2.996,60

 

L01EA01 194

DS

imatinibNL115

400 mg

188,73

198,17

O

Accord Healthcare S.L.U.

Accord Healthcare Limited

Imatinib Accord

tbl. film obl. 30x400 mg

188,73

198,17

5.661,90

5.945,00

 

L01EA02 161

DS

dasatinibNL119

100 mg

1.002,50

1.052,62

O

Bristol-Myers Squibb Pharma EEIG

Bristol-Myers Squibb

Sprycel

tbl. film obl. 60x20 mg

200,50

210,53

12.030,00

12.631,50

 

L01EA02 163

DS

dasatinibNL119

100 mg

603,42

633,59

O

Bristol-Myers Squibb Pharma EEIG

Bristol-Myers Squibb

Sprycel

tbl. film obl. 30x100 mg

603,42

633,59

18.102,60

19.007,73

 

L01EA02 171

DS

dasatinibNL119

100 mg

701,75

736,84

O

Zentiva k.s.

Synthon Hispania S.L., Synthon BV

Dasatinib Zentiva

tbl. film obl. 60x20 mg

140,35

147,37

8.421,00

8.842,05

 

L01EA02 172

DS

dasatinibNL119

100 mg

422,39

443,51

O

Zentiva k.s.

Synthon Hispania S.L., Synthon BV

Dasatinib Zentiva

tbl. film obl. 30x100 mg

422,39

443,51

12.671,82

13.305,41

 

L01EA03 171

DS

nilotinibNL121

600 mg

655,85

688,64

O

Novartis Europharm Limited Irska

Novartis Pharma Stein AG

Tasigna

caps. tvrda 112x200 mg

218,62

229,55

24.485,07

25.709,32

 

L01EA04 161

DS

bosutinibNL119

400 mg

704,91

740,16

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Bosulif

tbl. film obl. 28x100 mg

176,23

185,04

4.934,40

5.181,12

 

L01EA04 162

DS

bosutinibNL119

400 mg

706,20

741,51

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Bosulif

tbl. film obl. 28x500 mg

882,75

926,89

24.717,00

25.952,85

 

L01EA05 161

DS

ponatinibNL526

45 mg

2.093,90

2.198,60

O

Incyte Biosciences Distribution B.V.

Incyte Biosciences Distribution B.V.

Iclusig

tbl. film obl. 60x15 mg

697,97

732,87

41.878,00

43.971,90

 

L01EA05 162

DS

ponatinibNL526

45 mg

1.350,29

1.417,80

O

Incyte Biosciences Distribution B.V.

Incyte Biosciences Distribution B.V.

Iclusig

tbl. film obl. 30x45 mg

1.350,29

1.417,80

40.508,60

42.534,03

 

L01EB01 101

DS

gefitinibNL419

250 mg

248,34

260,76

O

PLIVA HRVATSKA d.o.o.

Pliva Hrvatska d.o.o.

Gefitinib Pliva

tbl. film obl. 30x250 mg

248,34

260,76

7.450,20

7.822,71

 

L01EB01 141

DS

gefitinibNL419

250 mg

235,92

247,72

O

Alkaloid-INT d.o.o.

Alkaloid - INT d.o.o.

Phrompo

tbl. film obl. 30x250 mg

235,92

247,72

7.077,69

7.431,57

 

L01EB01 171

DS

gefitinibNL419

250 mg

306,60

321,93

O

ALPHA-MEDICAL d.o.o.

Synthon Hispania S.L., Synthon BV

Gefitinib Alpha-Medical

tbl. film obl. 30x250 mg

306,60

321,93

9.198,00

9.657,90

 

L01EB01 181

DS

gefitinibNL419

250 mg

306,60

321,93

O

Sandoz d.o.o.

Remedica Ltd., Lek Pharmaceuticals d.d.

Gefitinib Sandoz

tbl. film obl. 30x250 mg

306,60

321,93

9.198,00

9.657,90

 

L01EB01 191

DS

gefitinibNL419

250 mg

275,94

289,74

O

Zentiva k.s.

Pharmadox Healthcare Limited, S.C Labormed - Pharma SA

Gefitinib Zentiva

tbl. film obl. 30x250 mg

275,94

289,74

8.278,20

8.692,11

 

L01EB02 161

DS

erlotinibNL116

150 mg

243,05

255,20

O

Roche Registration GmbH

Roche

Tarceva

tbl. film obl. 30x150 mg

243,05

255,20

7.291,46

7.656,03

 

L01EB02 162

DS

erlotinibNL116

150 mg

243,05

255,20

O

Zentiva k.s.

Remedica Ltd.

Varlota

tbl. film obl. 30x150 mg

243,05

255,20

7.291,46

7.656,03

 

L01EB02 163

DS

erlotinibNL116

150 mg

243,05

255,20

O

Remedica Ltd.

Remedica Ltd.

Erlotinib Remedica

tbl. film obl. 30x150 mg

243,05

255,20

7.291,46

7.656,03

 

L01EB02 164

DS

erlotinibNL116

150 mg

243,05

255,20

O

PharmaS d.o.o.

Remedica Ltd.

Erlotinib PharmaS

tbl. film obl. 30x150 mg

243,05

255,20

7.291,46

7.656,03

 

L01EB02 165

DS

erlotinibNL116

150 mg

243,05

255,20

O

ACTAVIS GROUP PTC ehf.

S.C. Sindan-Pharma S.R.L.

Erlotinib Actavis

tbl. film obl. 30x150 mg

243,05

255,20

7.291,46

7.656,03

 

L01EB02 166

DS

erlotinibNL116

150 mg

218,74

229,68

O

Sandoz d.o.o.

Lek Pharmaceuticals d.d., Remedica Ltd.

Erlotinib Sandoz

tbl. film obl. 30x150 mg

218,74

229,68

6.562,31

6.890,43

 

L01EB02 167

DS

erlotinibNL116

150 mg

196,87

206,71

O

Mylan S.A.S

Remedica Ltd.

Erlotinib Mylan

tbl. film obl. 30x150 mg

196,87

206,71

5.906,08

6.201,38

 

L01EB02 168

DS

erlotinibNL116

150 mg

187,03

196,38

O

KRKA-FARMA d.o.o.

Krka d.d.

Erlotinib Krka

tbl. film obl. 30x150 mg

187,03

196,38

5.610,78

5.891,32

 

L01EB03 161

DS

afatinibNL419

40 mg

1.032,76

1.084,40

O

Boehringer Ingelheim International GmbH

Boehringer Ingelheim

Giotrif

tbl. film obl. 28x20 mg

516,38

542,20

14.458,64

15.181,57

 

L01EB03 162

DS

afatinibNL419

40 mg

688,51

722,93

O

Boehringer Ingelheim International GmbH

Boehringer Ingelheim

Giotrif

tbl. film obl. 28x30 mg

516,38

542,20

14.458,64

15.181,57

 

L01EB03 163

DS

afatinibNL419

40 mg

516,38

542,20

O

Boehringer Ingelheim International GmbH

Boehringer Ingelheim

Giotrif

tbl. film obl. 28x40 mg

516,38

542,20

14.458,64

15.181,57

 

L01EB04 161

KS

osimertinibNL473

80 mg

3.037,70

3.189,59

O

AstraZeneca AB

AstraZeneca AB

Tagrisso

tbl. film obl. 28x40 mg

1.518,85

1.594,79

42.527,80

44.654,19

 

L01EB04 162

KS

osimertinibNL473

80 mg

1.518,85

1.594,79

O

AstraZeneca AB

AstraZeneca AB

Tagrisso

tbl. film obl. 28x80 mg

1.518,85

1.594,79

42.527,80

44.654,19

 

L01EC01 061

KS

vemurafenibNL422

1920 mg

1.716,24

1.802,05

O

Roche Registration GmbH

Roche Pharma AG

Zelboraf

tbl. film obl. 56x240 mg

214,53

225,26

12.013,68

12.614,36

 

L01EC02 162

KS

dabrafenibNL422

300 mg

1.576,26

1.655,07

O

Novartis Europharm Limited Irska

Glaxo Wellcome S.A.

Tafinlar

caps. tvrda 120x50 mg

262,71

275,85

31.525,20

33.101,46

 

L01EC02 163

KS

dabrafenibNL422

300 mg

1.584,39

1.663,61

O

Novartis Europharm Limited Irska

Glaxo Wellcome S.A.

Tafinlar

caps. tvrda 120x75 mg

396,10

415,90

47.531,60

49.908,18

 

L01ED01 161

DS

krizotinibNL444

500 mg

1.366,22

1.434,53

O

Pfizer Europe MA EEIG

Pfizer

Xalkori

caps. tvrda 60x200 mg

546,49

573,81

32.789,29

34.428,75

 

L01ED01 162

DS

krizotinibNL444

500 mg

1.092,98

1.147,63

O

Pfizer Europe MA EEIG

Pfizer

Xalkori

caps. tvrda 60x250 mg

546,49

573,81

32.789,29

34.428,75

 

L01ED03 161

DS

alektinibNL474

1200 mg

1.418,75

1.489,68

O

Roche Registration GmbH

Roche Pharma AG

Alecensa

caps. tvrda 224x150 mg

177,34

186,21

39.724,91

41.711,16

 

L01ED04 071

DS

brigatinibNL501

180 mg

1.377,96

1.446,86

O

Takeda Pharma A/S

Takeda Austria GmbH, Penn Pharmaceutical Services Limited

Alunbrig

tbl. film obl. 28x30 mg

229,66

241,14

6.430,48

6.752,00

 

L01ED04 072

DS

brigatinibNL501

180 mg

1.356,29

1.424,11

O

Takeda Pharma A/S

Takeda Austria GmbH, Penn Pharmaceutical Services Limited

Alunbrig

tbl. film obl. 28x90 mg

678,15

712,05

18.988,11

19.937,52

 

L01ED04 073

DS

brigatinibNL501

180 mg

1.128,97

1.185,42

O

Takeda Pharma A/S

Takeda Austria GmbH, Penn Pharmaceutical Services Limited

Alunbrig

tbl. film obl. 28x180 mg

1.128,97

1.185,42

31.611,16

33.191,72

 

L01ED04 074

DS

brigatinibNL501

180 mg

1.290,25

1.354,76

O

Takeda Pharma A/S

Takeda Austria GmbH, Penn Pharmaceutical Services Limited

Alunbrig

tbl. film obl. (7x90 mg+21x180 mg)

1.128,97

1.185,42

31.611,16

33.191,72

 

L01ED05 161

DS

lorlatinibNL511

100 mg

1.422,46

1.493,58

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Lorviqua

tbl. film obl. 90x25 mg

355,62

373,40

32.005,35

33.605,62

 

L01ED05 162

DS

lorlatinibNL511

100 mg

1.423,27

1.494,43

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Lorviqua

tbl. film obl. 120x25 mg

355,82

373,61

42.698,09

44.832,99

 

L01ED05 163

DS

lorlatinibNL511

100 mg

1.066,85

1.120,19

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Lorviqua

tbl. film obl. 30x100 mg

1.066,85

1.120,19

32.005,35

33.605,62

 

L01EE01 161

KS

trametinibNL422

2 mg

1.108,47

1.163,89

O

Novartis Europharm Limited Irska

Glaxo Wellcome, S.A., Novartis Pharmaceuticals UK Limited, Novartis Pharma GmbH

Mekinist

tbl. film obl. 30x0,5 mg

277,12

290,97

8.313,50

8.729,18

 

L01EE01 162

KS

trametinibNL422

2 mg

1.099,61

1.154,59

O

Novartis Europharm Limited Irska

Glaxo Wellcome, S.A., Novartis Pharmaceuticals UK Limited, Novartis Pharma GmbH

Mekinist

tbl. film obl. 30x2 mg

1.099,61

1.154,59

32.988,30

34.637,72

 

L01EE02 161

KS

kobimetinibNL422

45 mg

1.362,64

1.430,77

O

Roche Registration GmbH

Roche Pharma AG

Cotellic

tbl. film obl. 63x20 mg

605,62

635,90

38.153,85

40.061,54

 

L01EF01 161

DS

palbociklibNL478

94 mg

1.482,60

1.556,73

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Ibrance

caps. tvrda 21x75 mg

1.182,92

1.242,07

24.841,39

26.083,46

 

L01EF01 162

DS

palbociklibNL478

94 mg

1.111,95

1.167,55

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Ibrance

caps. tvrda 21x100 mg

1.182,92

1.242,07

24.841,39

26.083,46

 

L01EF01 163

DS

palbociklibNL478

94 mg

889,56

934,04

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Ibrance

caps. tvrda 21x125 mg

1.182,92

1.242,07

24.841,39

26.083,46

 

L01EF01 164

DS

palbociklibNL478

94 mg

1.211,49

1.272,07

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Ibrance

tbl. film obl. 21x75 mg

966,62

1.014,95

20.298,95

21.313,90

 

L01EF01 165

DS

palbociklibNL478

94 mg

908,62

954,05

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Ibrance

tbl. film obl. 21x100 mg

966,62

1.014,95

20.298,95

21.313,90

 

L01EF01 166

DS

palbociklibNL478

94 mg

726,90

763,24

O

Pfizer Europe MA EEIG

Pfizer Manufacturing Deutschland GmbH

Ibrance

tbl. film obl. 21x125 mg

966,62

1.014,95

20.298,95

21.313,90

 

L01EF02 161

DS

ribociklibNL479

450 mg

805,95

846,25

O

Novartis Europharm Limited Irska

Novartis Pharma GmbH

Kisqali

tbl. film obl. 63x200 mg

358,20

376,11

22.566,60

23.694,93

 

L01EF03 171

DS

abemaciklibNL498

300 mg

1.988,31

2.087,73

O

Eli Lilly Nederland B.V.

Lilly S.A.

Verzenios

tbl. film obl. 28x50 mg

331,39

347,95

9.278,78

9.742,72

 

L01EF03 172

DS

abemaciklibNL498

300 mg

994,16

1.043,86

O

Eli Lilly Nederland B.V.

Lilly S.A.

Verzenios

tbl. film obl. 28x100 mg

331,39

347,95

9.278,78

9.742,72

 

L01EF03 173

DS

abemaciklibNL498

300 mg

662,77

695,91

O

Eli Lilly Nederland B.V.

Lilly S.A.

Verzenios

tbl. film obl. 28x150 mg

331,39

347,95

9.278,78

9.742,72

 

L01EG01 071

DS

temsirolimusNL122

3.57 mg

764,60

802,83

P

Pfizer Europe MA EEIG

Wyeth

Torisel

konc. i otap. za inf. boč. stakl. 1x30 mg/1,2 ml+boč. stakl. 1x2,2 ml

6.425,25

6.746,51

6.425,25

6.746,51

 

L01EG01 081

DS

temsirolimusNL122

3.57 mg

535,22

561,99

P

Accord Healthcare Polska Sp. z o.o.

Accord Healthcare Polska Sp. z o.o., Accord Healthcare B.V.

Temsirolimus Accord

konc. i otap. za otop. za inf. boč. stakl. 30 mg, 1 boč. s konc. i 1 boč. s otap.

4.497,68

4.722,56

4.497,68

4.722,56

 

L01EG02 101

DS

everolimusNL420

10 mg

568,49

596,92

O

PLIVA HRVATSKA d.o.o.

Teva Gyogyszergyar Zrt.

Everolimus Pliva

tbl. 30x5 mg

284,25

298,46

8.527,39

8.953,76

 

L01EG02 102

DS

everolimusNL420

10 mg

388,32

407,73

O

PLIVA HRVATSKA d.o.o.

Teva Gyogyszergyar Zrt.

Everolimus Pliva

tbl. 30x10 mg

388,32

407,73

11.649,47

12.231,94

 

L01EG02 131

DS

everolimusNL420

10 mg

511,64

537,23

O

KRKA-FARMA d.o.o.

Synthon Hispania S.L., Synthon BV

Everolimus Krka

tbl. 30x2,5 mg

127,91

134,31

3.837,33

4.029,20

 

L01EG02 132

DS

everolimusNL420

10 mg

460,48

483,50

O

KRKA-FARMA d.o.o.

Synthon Hispania S.L., Synthon BV

Everolimus Krka

tbl. 90x2,5 mg

115,12

120,88

10.360,78

10.878,82

 

L01EG02 133

DS

everolimusNL420

10 mg

511,64

537,23

O

KRKA-FARMA d.o.o.

Synthon Hispania S.L., Synthon BV

Everolimus Krka

tbl. 30x5 mg

255,82

268,61

7.674,65

8.058,38

 

L01EG02 134

DS

everolimusNL420

10 mg

460,48

483,50

O

KRKA-FARMA d.o.o.

Synthon Hispania S.L., Synthon BV

Everolimus Krka

tbl. 90x5 mg

230,24

241,75

20.721,56

21.757,64

 

L01EG02 135

DS

everolimusNL420

10 mg

349,48

366,96

O

KRKA-FARMA d.o.o.

Synthon Hispania S.L., Synthon BV

Everolimus Krka

tbl. 30x10 mg

349,48

366,96

10.484,52

11.008,75

 

L01EG02 136

DS

everolimusNL420

10 mg

314,54

330,26

O

KRKA-FARMA d.o.o.

Synthon Hispania S.L., Synthon BV

Everolimus Krka

tbl. 90x10 mg

314,54

330,26

28.308,20

29.723,61

 

L01EG02 171

DS

everolimusNL420

10 mg

568,49

596,92

O

Alvogen Pharma Trading Europe EOOD

Genepharm S.A., Pharmadox Healthcare Limited

Everolimus Alvogen

tbl. 30x5 mg

284,25

298,46

8.527,39

8.953,76

 

L01EG02 172

DS

everolimusNL420

10 mg

388,32

407,73

O

Alvogen Pharma Trading Europe EOOD

Genepharm S.A., Pharmadox Healthcare Limited

Everolimus Alvogen

tbl. 30x10 mg

388,32

407,73

11.649,47

12.231,94

 

L01EG02 181

DS

everolimusNL420

10 mg

568,49

596,92

O

STADA d.o.o.

Stada Arzneimittel

Everolimus STADA

tbl. 30x5 mg

284,25

298,46

8.527,39

8.953,76

 

L01EG02 182

DS

everolimusNL420

10 mg

388,32

407,73

O

STADA d.o.o.

Stada Arzneimittel

Everolimus STADA

tbl. 30x10 mg

388,32

407,73

11.649,47

12.231,94

 

L01EG02 183

DS

everolimusNL420

10 mg

568,49

596,92

O

Mylan S.A.S

Synthon Hispania S.L., Synthon BV

Everolimus Mylan

tbl. 30x5 mg

284,25

298,46

8.527,39

8.953,76

 

L01EG02 184

DS

everolimusNL420

10 mg

388,32

407,73

O

Mylan S.A.S

Synthon Hispania S.L., Synthon BV

Everolimus Mylan

tbl. 30x10 mg

388,32

407,73

11.649,47

12.231,94

 

L01EG02 185

DS

everolimusNL420

10 mg

568,49

596,92

O

ALPHA-MEDICAL d.o.o.

Synthon Hispania S.L., Synthon BV

Everolimus Alpha-Medical

tbl. 30x5 mg

284,25

298,46

8.527,39

8.953,76

 

L01EG02 186

DS

everolimusNL420

10 mg

388,32

407,73

O

ALPHA-MEDICAL d.o.o.

Synthon Hispania S.L., Synthon BV

Everolimus Alpha-Medical

tbl. 30x10 mg

388,32

407,73

11.649,47

12.231,94

 

L01EH01 161

DS

lapatinibNL120

1250 mg

581,80

610,89

O

Novartis Europharm Limited Irska

Glaxo Operations UK Ltd; Glaxo Wellcome S.A., Novartis Pharmaceuticals UK Limited, Novartis Pharma GmbH

Tyverb

tbl. film obl. 70x250 mg

116,36

122,18

8.145,20

8.552,46

 

L01EJ01 161

DS

ruksolitinibNL453

30 mg

1.518,20

1.594,11

O

Novartis Europharm Limited Irska

Novartis Pharma GmbH

Jakavi

tbl. 56x5 mg

253,03

265,69

14.169,87

14.878,36

 

L01EJ01 162

DS

ruksolitinibNL453

30 mg

994,82

1.044,56

O

Novartis Europharm Limited Irska

Novartis Pharma GmbH

Jakavi

tbl. 56x15 mg

497,41

522,28

27.855,00

29.247,75

 

L01EJ01 163

DS

ruksolitinibNL453

30 mg

746,12

783,42

O

Novartis Europharm Limited Irska

Novartis Pharma GmbH

Jakavi

tbl. 56x20 mg

497,41

522,28

27.855,00

29.247,75

 

L01EK01 161

DS

aksitinibNL430

10 mg

799,20

839,16

O

Pfizer Europe MA EEIG

Pfizer

Inlyta

tbl. film obl. 56x1 mg

79,92

83,92

4.475,52

4.699,30

 

L01EK01 162

DS

aksitinibNL430

10 mg

799,20

839,16

O

Pfizer Europe MA EEIG

Pfizer

Inlyta

tbl. film obl. 56x5 mg

399,60

419,58

22.377,60

23.496,48

 

L01EL01 161

DS

ibrutinibNL502

420 mg

1.350,39

1.417,91

O

Janssen-Cilag International N.V.

Janssen

Imbruvica

caps. tvrda 90x140 mg

450,13

472,64

40.511,70

42.537,29

 

L01EL01 162

DS

ibrutinibNL471

420 mg

1.349,80

1.417,29

O

Janssen-Cilag International N.V.

Janssen

Imbruvica

caps. tvrda 120x140 mg

449,93

472,43

53.992,00

56.691,60

 

L01EL01 163

DS

ibrutinibNL527

420 mg

1.349,80

1.417,29

O

Janssen-Cilag International N.V.

Janssen-Cilag SpA

Imbruvica

tbl. film obl. 28x140 mg

449,93

472,43

12.598,13

13.228,04

 

L01EL01 164

DS

ibrutinibNL527

420 mg

1.349,80

1.417,29

O

Janssen-Cilag International N.V.

Janssen-Cilag SpA

Imbruvica

tbl. film obl. 28x280 mg

899,87

944,86

25.196,27

26.456,08

 

L01EL01 165

DS

ibrutinibNL527

420 mg

1.349,80

1.417,29

O

Janssen-Cilag International N.V.

Janssen-Cilag SpA

Imbruvica

tbl. film obl. 28x420 mg

1.349,80

1.417,29

37.794,40

39.684,12

 

L01EL01 166

DS

ibrutinibNL471

420 mg

1.349,80

1.417,29

O

Janssen-Cilag International N.V.

Janssen-Cilag SpA

Imbruvica

tbl. film obl. 28x560 mg

1.799,73

1.889,72

50.392,53

52.912,16

 

L01EM01 161

DS

idelalisibNL454

300 mg

1.371,48

1.440,05

O

Gilead Sciences Ireland UC

Gilead Sciences Ireland UC

Zydelig

tbl. film obl. 60x100 mg

457,16

480,02

27.429,60

28.801,08

 

L01EM01 162

DS

idelalisibNL454

300 mg

914,32

960,04

O

Gilead Sciences Ireland UC

Gilead Sciences Ireland UC

Zydelig

tbl. film obl. 60x150 mg

457,16

480,02

27.429,60

28.801,08

 

L01EX01 101

DS

sunitinibNL117

33 mg

557,72

585,61

O

PLIVA HRVATSKA d.o.o.

Pliva Hrvatska d.o.o., Teva Operations Poland Sp. z o.o.

Sunitinib Pliva

caps. tvrda 28x12,5 mg

211,26

221,82

5.915,22

6.210,98

 

L01EX01 102

DS

sunitinibNL117

33 mg

555,17

582,93

O

PLIVA HRVATSKA d.o.o.

Pliva Hrvatska d.o.o., Teva Operations Poland Sp. z o.o.

Sunitinib Pliva

caps. tvrda 28x25 mg

420,59

441,62

11.776,40

12.365,22

 

L01EX01 103

DS

sunitinibNL117

33 mg

552,92

580,57

O

PLIVA HRVATSKA d.o.o.

Pliva Hrvatska d.o.o., Teva Operations Poland Sp. z o.o.

Sunitinib Pliva

caps. tvrda 28x50 mg

837,76

879,65

23.457,41

24.630,28

 

L01EX01 131

DS

sunitinibNL117

33 mg

557,73

585,61

O

KRKA-FARMA d.o.o.

Krka d.d, Krka - farma d.o.o.

Sunitinib Krka

caps. tvrda 30x12,5 mg

211,26

221,82

6.337,80

6.654,69

 

L01EX01 132

DS

sunitinibNL117

33 mg

555,18

582,94

O

KRKA-FARMA d.o.o.

Krka d.d, Krka - farma d.o.o.

Sunitinib Krka

caps. tvrda 30x25 mg

420,59

441,62

12.617,70

13.248,59

 

L01EX01 133

DS

sunitinibNL117

33 mg

552,92

580,57

O

KRKA-FARMA d.o.o.

Krka d.d, Krka - farma d.o.o.

Sunitinib Krka

caps. tvrda 30x50 mg

837,76

879,65

25.132,80

26.389,44

 

L01EX01 164

DS

sunitinibNL117

33 mg

796,74

836,58

O

Pfizer Europe MA EEIG

Pfizer

Sutent

caps. tvrda 28x12,5 mg

301,80

316,89

8.450,31

8.872,83

 

L01EX01 165

DS

sunitinibNL117

33 mg

793,10

832,76

O

Pfizer Europe MA EEIG

Pfizer

Sutent

caps. tvrda 28x25 mg

600,84

630,88

16.823,43

17.664,60

 

L01EX01 166

DS

sunitinibNL117

33 mg

789,89

829,39

O

Pfizer Europe MA EEIG

Pfizer

Sutent

caps. tvrda 28x50 mg

1.196,81

1.256,65

33.510,59

35.186,12

 

L01EX01 171

DS

sunitinibNL117

33 mg

529,83

556,33

O

STADA d.o.o.

STADA Arzneimittel AG, STADA Arzneimittel GmbH

Sunitinib Stada

caps. tvrda 28x12,5 mg

200,70

210,73

5.619,46

5.900,43

 

L01EX01 172

DS

sunitinibNL117

33 mg

527,41

553,79

O

STADA d.o.o.

STADA Arzneimittel AG, STADA Arzneimittel GmbH

Sunitinib Stada

caps. tvrda 28x25 mg

399,56

419,53

11.187,58

11.746,96

 

L01EX01 173

DS

sunitinibNL117

33 mg

525,28

551,54

O

STADA d.o.o.

STADA Arzneimittel AG, STADA Arzneimittel GmbH

Sunitinib Stada

caps. tvrda 28x50 mg

795,88

835,67

22.284,54

23.398,77

 

L01EX01 174

DS

sunitinibNL117

33 mg

529,83

556,33

O

Accord Healthcare S.L.U.

Remedica Ltd., Pharmacare Premium Ltd.

Sunitinib Accord

caps. tvrda 30x12,5 mg

200,70

210,73

6.020,85

6.321,89

 

L01EX01 175

DS

sunitinibNL117

33 mg

527,41

553,79

O

Accord Healthcare S.L.U.

Remedica Ltd., Pharmacare Premium Ltd.

Sunitinib Accord

caps. tvrda 30x25 mg

399,56

419,53

11.986,69

12.586,02

 

L01EX01 176

DS

sunitinibNL117

33 mg

525,28

551,54

O

Accord Healthcare S.L.U.

Remedica Ltd., Pharmacare Premium Ltd.

Sunitinib Accord

caps. tvrda 30x50 mg

795,88

835,67

23.876,29

25.070,10

 

L01EX01 177

DS

sunitinibNL117

33 mg

529,83

556,33

O

Sandoz d.o.o.

Remedica Ltd., Lek Pharmaceuticals d.d.

Sunitinib Sandoz

caps. tvrda 28x12,5 mg

200,70

210,73

5.619,46

5.900,43

 

L01EX01 178

DS

sunitinibNL117

33 mg

527,41

553,79

O

Sandoz d.o.o.

Remedica Ltd., Lek Pharmaceuticals d.d.

Sunitinib Sandoz

caps. tvrda 28x25 mg

399,56

419,53

11.187,58

11.746,96

 

L01EX01 179

DS

sunitinibNL117

33 mg

525,28

551,54

O

Sandoz d.o.o.

Remedica Ltd., Lek Pharmaceuticals d.d.

Sunitinib Sandoz

caps. tvrda 28x50 mg

795,88

835,67

22.284,54

23.398,77

 

L01EX01 181

DS

sunitinibNL117

33 mg

503,34

528,51

O

Mylan Ireland Limited

Remedica Ltd., Pharmacare Premium Ltd.

Sunitinib Mylan

caps. tvrda 28x12,5 mg

190,66

200,19

5.338,49

5.605,41

 

L01EX01 182

DS

sunitinibNL117

33 mg

501,04

526,10

O

Mylan Ireland Limited

Remedica Ltd., Pharmacare Premium Ltd.

Sunitinib Mylan

caps. tvrda 28x25 mg

379,58

398,56

10.628,20

11.159,61

 

L01EX01 183

DS

sunitinibNL117

33 mg

499,01

523,97

O

Mylan Ireland Limited

Remedica Ltd., Pharmacare Premium Ltd.

Sunitinib Mylan

caps. tvrda 28x50 mg

756,08

793,89

21.170,31

22.228,83

 

L01EX01 184

DS

sunitinibNL117

33 mg

478,18

502,09

O

ALPHA-MEDICAL d.o.o.

Synthon s.r.o., Synthon BV

Sunitinib Alpha-Medical

caps. tvrda 28x12,5 mg

181,13

190,18

5.071,57

5.325,15

 

L01EX01 185

DS

sunitinibNL117

33 mg

475,99

499,79

O

ALPHA-MEDICAL d.o.o.

Synthon s.r.o., Synthon BV

Sunitinib Alpha-Medical

caps. tvrda 28x25 mg

360,60

378,63

10.096,79

10.601,63

 

L01EX01 186

DS

sunitinibNL117

33 mg

474,06

497,77

O

ALPHA-MEDICAL d.o.o.

Synthon s.r.o., Synthon BV

Sunitinib Alpha-Medical

caps. tvrda 28x50 mg

718,28

754,19

20.111,79

21.117,38

 

L01EX01 187

DS

sunitinibNL117

33 mg

478,18

502,09

O

Zentiva k.s.

Remedica Ltd., Pharmacare Premium Ltd.

Zesuva

caps. tvrda 28x12,5 mg

181,13

190,18

5.071,57

5.325,15

 

L01EX01 188

DS

sunitinibNL117

33 mg

475,99

499,79

O

Zentiva k.s.

Remedica Ltd., Pharmacare Premium Ltd.

Zesuva

caps. tvrda 28x25 mg

360,60

378,63

10.096,79

10.601,63

 

L01EX01 189

DS

sunitinibNL117

33 mg

474,06

497,77

O

Zentiva k.s.

Remedica Ltd., Pharmacare Premium Ltd.

Zesuva

caps. tvrda 28x50 mg

718,28

754,19

20.111,79

21.117,38

 

L01EX02 171

KLDS

sorafenibNL118

800 mg

586,06

615,36

O

Bayer AG

Bayer HealthCare AG

Nexavar

tbl. film obl. 112x200 mg

146,51

153,84

16.409,65

17.230,13

 

L01EX02 172

KLDS

sorafenibNL517

800 mg

586,06

615,36

O

Mylan Ireland Limited

Remedica Ltd.

Sorafenib Mylan

tbl. film obl. 112x200 mg

146,51

153,84

16.409,65

17.230,13

 

L01EX02 173

KLDS

sorafenibNL517

800 mg

586,06

615,36

O

STADA d.o.o.

STADA Arzneimittel AG, STADA Arzneimittel GmbH

Sorafenib Stada

tbl. film obl. 112x200 mg

146,51

153,84

16.409,65

17.230,13

 

L01EX02 174

KLDS

sorafenibNL517

800 mg

586,06

615,36

O

Teva B.V.

Pliva Hrvatska d.o.o., Teva Operations Poland Sp. z o.o.

Sorafenib Teva

tbl. film obl. 112x200 mg

146,51

153,84

16.409,65

17.230,13

 

L01EX02 175

KLDS

sorafenibNL517

800 mg

556,76

584,59

O

Sandoz d.o.o.

Remedica Ltd., Lek Pharmaceuticals d.d.

Sorafenib Sandoz

tbl. film obl. 112x200 mg

139,19

146,15

15.589,17

16.368,63

 

L01EX02 176

KLDS

sorafenibNL517

800 mg

556,76

584,59

O

Zentiva k.s.

Remedica Ltd.

Fenesa

tbl. film obl. 112x200 mg

139,19

146,15

15.589,17

16.368,63

 

L01EX02 177

KLDS

sorafenibNL517

800 mg

528,92

555,36

O

Pharmascience International Limited

Remedica Ltd., PharOS MT Ltd.

Sorafenib Pharmascience

tbl. film obl. 112x200 mg

132,23

138,84

14.809,71

15.550,20

 

L01EX03 161

KLDS

pazopanibNL421

800 mg

699,71

734,69

O

Novartis Europharm Limited Irska

Glaxo Operations UK Ltd, Glaxo Wellcome, S.A.

Votrient

tbl. film obl. 30x200 mg

174,93

183,67

5.247,80

5.510,19

 

L01EX03 162

KLDS

pazopanibNL421

800 mg

688,81

723,25

O

Novartis Europharm Limited Irska

Glaxo Operations UK Ltd, Glaxo Wellcome, S.A.

Votrient

tbl. film obl. 30x400 mg

344,40

361,62

10.332,10

10.848,71

 

L01EX05 161

DS

regorafenibNL470

120 mg

603,92

634,12

O

Bayer AG

Bayer AG

Stivarga

tbl. film obl. 84x40 mg

201,31

211,37

16.909,76

17.755,25

 

L01EX09 161

KS

nintedanibNL455

380 mg

800,98

841,03

O

Boehringer Ingelheim International GmbH

Boehringer Ingelheim Pharma GmbH

Ofev

caps. meka 60x100 mg

210,78

221,32

12.647,00

13.279,35

 

L01EX09 162

KS

nintedanibNL455

380 mg

738,81

775,75

O

Boehringer Ingelheim International GmbH

Boehringer Ingelheim Pharma GmbH

Ofev

caps. meka 60x150 mg

291,64

306,22

17.498,20

18.373,11

 

L01EX09 171

DS

nintedanibNL472

380 mg

538,88

565,82

O

Boehringer Ingelheim International GmbH

Boerhinger Ingelheim

Vargatef

caps. meka 120x100 mg

141,81

148,90

17.017,24

17.868,10

 

L01EX09 172

DS

nintedanibNL472

380 mg

718,51

754,43

O

Boehringer Ingelheim International GmbH

Boerhinger Ingelheim

Vargatef

caps. meka 60x150 mg

283,62

297,80

17.017,24

17.868,10

 

L01EX10 171

KL

midostaurinNL489

100 mg

3.549,21

3.726,67

O

Novartis Europharm Limited Irska

Novartis Pharma GmbH

Rydapt

caps. meka 112x25 mg

887,30

931,67

99.377,85

104.346,74

 

L01FA01 061

DS

rituksimabNL518

 

 

 

P

Roche Registration GmbH

Roche

Mabthera

boč. 2x100 mg/10 ml

1.520,08

1.596,08

3.040,16

3.192,17

 

L01FA01 062

DS

rituksimabNL518

 

 

 

P

Roche Registration GmbH

Roche

Mabthera

boč. 1x500 mg/50 ml

7.464,09

7.837,29

7.464,09

7.837,29

 

L01FA01 063

DS

rituksimabNL429

 

 

 

P

Roche Registration GmbH

Roche

Mabthera

otop. za supkut. inj., boč. 1x1400 mg

10.504,25

11.029,46

10.504,25

11.029,46

 

L01FA01 071

DS

rituksimabNL518

 

 

 

P

Celltrion Healthcare Hungary Kft.

Biotec Services International Ltd.

Truxima

konc. za otop. za inf., boč. stakl. 1x500 mg/50 ml

7.464,09

7.837,29

7.464,09

7.837,29

 

L01FA01 072

DS

rituksimabNL518

 

 

 

P

Celltrion Healthcare Hungary Kft.

Biotec Services International Ltd.

Truxima

konc. za otop. za inf., boč. stakl. 2x100 mg/10 ml

1.520,08

1.596,08

3.040,16

3.192,17

 

L01FA01 081

DS

rituksimabNL518

 

 

 

P

Sandoz GmbH

Sandoz GmbH

Rixathon

konc. za otop. za inf., boč. stakl. 2x100 mg/10 ml

1.368,07

1.436,47

2.736,14

2.872,95

 

L01FA01 082

DS

rituksimabNL518

 

 

 

P

Sandoz GmbH

Sandoz GmbH

Rixathon

konc. za otop. za inf., boč. stakl. 1x500 mg/50 ml

6.717,68

7.053,56

6.717,68

7.053,56

 

L01FA01 083

DS

rituksimabNL111

 

 

 

P

Pfizer Europe MA EEIG

Pfizer Manufacturing Belgium NV

Ruxience

konc. za otop. za inf., boč. stakl. 1x100 mg/10 ml

1.299,67

1.364,65

1.299,67

1.364,65

 

L01FA01 084

DS

rituksimabNL111

 

 

 

P

Pfizer Europe MA EEIG

Pfizer Manufacturing Belgium NV

Ruxience

konc. za otop. za inf., boč. stakl. 1x500 mg/50 ml

6.381,80

6.700,89

6.381,80

6.700,89

 

L01FA03 061

DS

obinutuzumabNL451

 

 

 

P

Roche Registration GmbH

Roche Pharma AG

Gazyvaro

konc. za otop. za inf., boč. stakl. 1x1000 mg/40 ml

24.898,97

26.143,92

24.898,97

26.143,92

 

L01FC01 071

KS

daratumumabNL492

 

 

 

P

Janssen-Cilag International N.V.

Janssen Biologics B.V

Darzalex

konc. za otop. za inf., boč. stakl. 1x100 mg/5 ml

3.221,44

3.382,51

3.221,44

3.382,51

 

L01FC01 072

KS

daratumumabNL492

 

 

 

P

Janssen-Cilag International N.V.

Janssen Biologics B.V

Darzalex

konc. za otop. za inf., boč. stakl. 1x400 mg/20 ml

12.649,05

13.281,50

12.649,05

13.281,50

 

L01FC01 073

KS

daratumumabNL492

 

 

 

P

Janssen-Cilag International N.V.

Janssen Biologics B.V

Darzalex

otop. za supkut. inj., boč. 1x1800 mg/15 ml

38.207,30

40.117,67

38.207,30

40.117,67

 

L01FD01 061

DS

trastuzumab NL112

 

 

 

P

Roche Registration GmbH

Roche

Herceptin

boč. 1x150 mg

2.935,41

3.082,18

2.935,41

3.082,18

 

L01FD01 062

DS

trastuzumab NL487

 

 

 

P

Roche Registration GmbH

Roche

Herceptin

otop. za supkut. inj., boč. 1x600 mg/5 ml

8.806,23

9.246,54

8.806,23

9.246,54

 

L01FD01 071

DS

trastuzumab NL112

 

 

 

P

Celltrion Healthcare Hungary Kft.

Biotec Services International Ltd

Herzuma

boč. 1x150 mg

2.935,41

3.082,18

2.935,41

3.082,18

 

L01FD01 072

DS

trastuzumab NL112

 

 

 

P

Mylan S.A.S

McDermott Laboratories Limited T/A Mylan Dublin Biologics

Ogivri

boč. 1x150 mg

2.788,64

2.928,07

2.788,64

2.928,07

 

L01FD01 081

DS

trastuzumab NL112

 

 

 

P

Amgen Europe B.V.

Amgen Europe B.V.

Kanjinti

boč. 1x150 mg

2.935,41

3.082,18

2.935,41

3.082,18

 

L01FD01 082

DS

trastuzumab NL112

 

 

 

P

Amgen Europe B.V.

Amgen Europe B.V.

Kanjinti

boč. 1x420 mg

8.219,15

8.630,11

8.219,15

8.630,11

 

L01FD01 083

DS

trastuzumab NL112

 

 

 

P

Pfizer Europe MA EEIG

Wyeth Pharmaceuticals, Pfizer Manufacturing Belgium NV

Trazimera

boč. 1x150 mg

2.935,41

3.082,18

2.935,41

3.082,18

 

L01FD01 084

DS

trastuzumab NL112

 

 

 

P

Accord Healthcare S.L.U.

Accord Healthcare Limited, Accord Healthcare Polska Sp. z o.o.

Zercepac

boč. 1x150 mg

2.649,21

2.781,67

2.649,21

2.781,67

 

L01FD01 085

DS

trastuzumab NL112

 

 

 

P

Accord Healthcare S.L.U.

Accord Healthcare Limited, Accord Healthcare Polska Sp. z o.o.

Zercepac

boč. 1x60 mg

1.006,70

1.057,04

1.006,70

1.057,04

 

L01FD01 086

DS

trastuzumab NL112

 

 

 

P

Accord Healthcare S.L.U.

Accord Healthcare Limited, Accord Healthcare Polska Sp. z o.o.

Zercepac

boč. 1x420 mg

7.311,82

7.677,41

7.311,82

7.677,41

 

L01FD02 061

DS

pertuzumabNL443

 

 

 

P

Roche Registration GmbH

Roche Pharma AG

Perjeta

konc. za otop. za inf., boč. stakl. 1x420 mg

19.988,62

20.988,05

19.988,62

20.988,05

 

L01FD03 061

DS

trastuzumab emtanzinNL450

 

 

 

P

Roche Registration GmbH

Roche Pharma AG

Kadcyla

praš. za konc. za otop. za inf., boč. stakl. 1x100 mg

12.739,00

13.375,95

12.739,00

13.375,95

 

L01FD03 062

DS

trastuzumab emtanzinNL450

 

 

 

P

Roche Registration GmbH

Roche Pharma AG

Kadcyla

praš. za konc. za otop. za inf., boč. stakl. 1x160 mg

20.376,00

21.394,80

20.376,00

21.394,80

 

L01FE01 061

DS

cetuksimabNL113

 

 

 

P

Merck Europe B.V.

Merck Healthcare KGaA

Erbitux

otop. za inf., boč. 1x20 ml (5 mg/ml)

1.389,84

1.459,33

1.389,84

1.459,33

 

L01FE02 061

DS

panitumumabNL431

 

 

 

P

Amgen Europe B.V.

Amgen Europe B.V.

Vectibix

konc. za otop. za inf., boč. 1x5 ml (20 mg/ml)

2.763,47

2.901,64

2.763,47

2.901,64

 

L01FF01 061

KS

nivolumabNL467

 

 

 

P

Bristol-Myers Squibb Pharma EEIG

Bristol - Myers Squibb S.r.l.

Opdivo

konc. za otop. za inf., boč. stakl. 1x4 ml (10 mg/ml)

3.953,05

4.150,70

3.953,05

4.150,70

 

L01FF01 062

KS

nivolumabNL467

 

 

 

P

Bristol-Myers Squibb Pharma EEIG

Bristol - Myers Squibb S.r.l.

Opdivo

konc. za otop. za inf., boč. stakl. 1x10 ml (10 mg/ml)

9.759,60

10.247,58

9.759,60

10.247,58

 

L01FF01 063

KS

nivolumabNL467

 

 

 

P

Bristol-Myers Squibb Pharma EEIG

Bristol - Myers Squibb S.r.l.

Opdivo

konc. za otop. za inf., boč. stakl. 1x24 ml (10 mg/ml)

23.472,25

24.645,86

23.472,25

24.645,86

 

L01FF02 062

KS

pembrolizumabNL452

 

 

 

P

Merck Sharp & Dohme B.V.

Schering - Plough Labo NV

Keytruda

konc. za otop. za inf., boč. stakl. 1x100 mg/4 ml (25 mg/ml)

22.683,16

23.817,32

22.683,16

23.817,32

 

L01FF03 061

KS

durvalumabNL515

 

 

 

P

AstraZeneca AB

AstraZeneca Pharmaceuticals LP

Imfinzi

konc. za otop. za inf., boč. stakl. 1x120 mg/2,4 ml (50mg/ml)

4.927,37

5.173,74

4.927,37

5.173,74

 

L01FF03 062

KS

durvalumabNL515

 

 

 

P

AstraZeneca AB

AstraZeneca Pharmaceuticals LP

Imfinzi

konc. za otop. za inf., boč. stakl. 1x500 mg/10 ml (50mg/ml)

20.224,46

21.235,68

20.224,46

21.235,68

 

L01FF04 061

KL

avelumabNL519

 

 

 

P

Merck Europe B.V.

Merck Serono S.p.A.

Bavencio

konc. za otop. za inf. 10 ml, boč. stakl. 1x20 mg/ml

6.947,17

7.294,53

6.947,17

7.294,53

 

L01FF05 071

KS

atezolizumabNL529

 

 

 

P

Roche Registration GmbH

Roche Pharma AG

Tecentriq

konc. otop. za inf., boč. 1x1200 mg/20 ml

30.555,70

32.083,49

30.555,70

32.083,49

 

L01FF05 072

KS

atezolizumabNL529

 

 

 

P

Roche Registration GmbH

Roche Pharma AG

Tecentriq

konc. otop. za inf., boč. 1x840 mg/14 ml

21.388,99

22.458,44

21.388,99

22.458,44

 

L01FG01 061

DS

bevacizumab NL128

 

 

 

P

Roche Registration GmbH

Roche

Avastin

konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml)

1.954,83

2.052,57

1.954,83

2.052,57

 

L01FG01 062

DS

bevacizumabNL128

 

 

 

P

Roche Registration GmbH

Roche

Avastin

konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml)

7.274,05

7.637,75

7.274,05

7.637,75

 

L01FG01 071

DS

bevacizumab NL128

 

 

 

P

Amgen Technology (Ireland) UC

Amgen Technology (Ireland) UC

Mvasi

konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml)

1.835,66

1.927,44

1.835,66

1.927,44

 

L01FG01 072

DS

bevacizumab NL128

 

 

 

P

Amgen Technology (Ireland) UC

Amgen Technology (Ireland) UC

Mvasi

konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml)

7.015,60

7.366,38

7.015,60

7.366,38

 

L01FG01 073

DS

bevacizumab NL128

 

 

 

P

Mabxience Research S.L.

GH Genhelix S.A.

Alymsys

konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml)

1.743,88

1.831,07

1.743,88

1.831,07

 

L01FG01 074

DS

bevacizumab NL128

 

 

 

P

Mabxience Research S.L.

GH Genhelix S.A.

Alymsys

konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml)

6.664,82

6.998,06

6.664,82

6.998,06

 

L01FG01 075

DS

bevacizumab NL128

 

 

 

P

STADA Arzneimittel AG

GH GENHELIX S.A.

Oyavas

konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml)

1.743,88

1.831,07

1.743,88

1.831,07

 

L01FG01 076

DS

bevacizumab NL128

 

 

 

P

STADA Arzneimittel AG

GH GENHELIX S.A.

Oyavas

konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml)

6.664,82

6.998,06

6.664,82

6.998,06

 

L01FG01 077

DS

bevacizumab NL128

 

 

 

P

Mylan IRE Healthcare Ltd

McDermott Laboratories Limited t/a Mylan Dublin Biologics, Mylan Germany GmbH

Abevmy

konc. otop. za inf., boč. 1x100 mg/4 ml (25 mg/ml)

1.656,69

1.739,52

1.656,69

1.739,52

 

L01FG01 078

DS

bevacizumab NL128

 

 

 

P

Mylan IRE Healthcare Ltd

McDermott Laboratories Limited t/a Mylan Dublin Biologics, Mylan Germany GmbH

Abevmy

konc. otop. za inf., boč. 1x400 mg/16 ml (25 mg/ml)

6.331,58

6.648,16

6.331,58

6.648,16

 

L01FG02 061

KS

ramucirumabNL469

 

 

 

P

Eli Lilly Nederland B.V.

Lilly, S.A.

Cyramza

konc. za otop. za inf., boč. stakl. 2x10 ml (10 mg/ml)

3.822,69

4.013,82

7.645,38

8.027,65

 

L01FX02 061

KS

gemtuzumab ozogamicinNL525

 

 

 

P

Pfizer Europe MA EEIG

Pfizer Ireland Pharmaceuticals

Mylotarg

praš. za konc. za otop. za inf., boč. stakl. 1x5 mg

57.699,86

60.584,85

57.699,86

60.584,85

 

L01FX04 061

KS

ipilimumabNL523

 

 

 

P

Bristol-Myers Squibb Pharma EEIG

CATALENT ANAGNI S.R.L., Swords Laboratories T/A Bristol-Myers Squibb Cruiserath Biologics

Yervoy

konc. za otop. za inf., boč. stakl. 1x10 ml (5 mg/ml)

26.558,64

27.886,57

26.558,64

27.886,57

 

L01FX05 061

DS

brentuksimab vedotinNL442

 

 

 

P

Takeda Pharma A/S

Takeda Italia S.p.A.

Adcetris

praš. za konc. za otop. za inf., boč. stakl. 1x50 mg

22.143,91

23.251,11

22.143,91

23.251,11

 

L01FX06 061

KL

dinutuksimab betaNL508

 

 

 

P

EUSA Pharma (Netherlands) B.V.

Millmount Healthcare Ltd

Qarziba

konc. za otop. za inf., boč. stakl. 1x20 mg (4,5 mg/ml)

69.464,16

72.937,37

69.464,16

72.937,37

 

L01EM03 171

DS

alpelisibNL531

300 mg

1.045,34

1.097,61

O

Novartis Europharm Limited Irska

Novartis Pharma GmbH

Piqray

tbl. film obl. 28x50 mg + 28x200 mg

435,56

457,34

24.391,36

25.610,93

 

L01EM03 172

DS

alpelisibNL531

300 mg

871,12

914,68

O

Novartis Europharm Limited Irska

Novartis Pharma GmbH

Piqray

tbl. film obl. 56x150 mg

435,56

457,34

24.391,36

25.610,93

 

L01EM03 173

DS

alpelisibNL531

300 mg

1.306,68

1.372,01

O

Novartis Europharm Limited Irska

Novartis Pharma GmbH

Piqray

tbl. film obl. 28x200 mg

871,12

914,68

24.391,36

25.610,93

 

L02BB06 161

DS

darolutamidNL514

120 mg

80,64

84,67

O

Bayer AG

Orion Corporation, Orion Pharma

Nubeqa

tbl. film obl. 112x300 mg

201,59

211,67

22.578,08

23.706,98

 

L04AA43 061

KL

ravulizumab NL524

58.9 mg

6.372,84

6.691,48

P

Alexion Europe SAS

Alexion Pharma International Operations Unlimited Company

Ultomiris

konc. za otop. za inf., boč. stakl. 1x300 mg (30 ml, 10 mg/ml)

32.459,30

34.082,27

32.459,30

34.082,27

 

L04AA44 161

 

upadacitinibNL512

15 mg

180,25

189,27

O

AbbVie Deutschland GmbH & Co. KG

AbbVie S.r.l.

Rinvoq

tbl. s prod. oslob. 28x15 mg

180,25

189,27

5.047,08

5.299,43

RSRL107

N02CC01 162

 

sumatriptan

50 mg

9,36

9,82

O

GlaxoSmithKline Trading Services Limited

GlaxoSmithKline Pharmaceuticals S.A.

Imigran

tbl. 2x50 mg

9,36

9,82

18,71

19,65

RSRN03

N03AX09 175

 

lamotrigin

0,3 g

4,31

4,52

O

GlaxoSmithKline Trading Services Limited

GlaxoSmithKline Pharmaceuticals S.A.

Lamictal

tbl. 56x25 mg

0,36

0,38

20,11

21,12

RSRN22

N03AX09 176

 

lamotrigin

0,3 g

6,70

7,03

O

GlaxoSmithKline Trading Services Limited

GlaxoSmithKline Pharmaceuticals S.A.

Lamictal

tbl. 56x50 mg

1,12

1,17

62,50

65,63

RSRN22

N03AX09 177

 

lamotrigin

0,3 g

5,85

6,14

O

GlaxoSmithKline Trading Services Limited

GlaxoSmithKline Pharmaceuticals S.A.

Lamictal

tbl. 56x100 mg

1,95

2,05

109,20

114,66

RSRN22

N03AX09 180

 

lamotrigin

0,3 g

55,20

57,96

O

GlaxoSmithKline Trading Services Limited

GlaxoSmithKline Pharmaceuticals S.A.

Lamictal

tbl. za žvak./oral. susp. 60x5 mg

0,92

0,97

55,20

57,96

RSRN22

N04BC04 176

 

ropinirol

6 mg

9,66

10,14

O

GlaxoSmithKline Trading Services Limited

GlaxoSmithKline Pharmaceuticals S.A., Glaxo Wellcome GmbH&Co.KG, Glaxo Wellcome S.A., SmithKline Beecham Plc

Requip Modutab

tbl. s prod. oslob. 28x2 mg

2,29

2,40

64,12

67,33

R

N04BC04 177

 

ropinirol

6 mg

9,15

9,60

O

GlaxoSmithKline Trading Services Limited

GlaxoSmithKline Pharmaceuticals S.A., Glaxo Wellcome GmbH&Co.KG, Glaxo Wellcome S.A., SmithKline Beecham Plc

Requip Modutab

tbl. s prod. oslob. 28x4 mg

4,48

4,70

125,31

131,58

R

N04BC04 178

 

ropinirol

6 mg

8,09

8,50

O

GlaxoSmithKline Trading Services Limited

GlaxoSmithKline Pharmaceuticals S.A., Glaxo Wellcome GmbH&Co.KG, Glaxo Wellcome S.A., SmithKline Beecham Plc

Requip Modutab

tbl. s prod. oslob. 28x8 mg

8,51

8,94

238,28

250,19

R

N06AB05 111

 

paroksetin

20 mg

0,64

0,68

O

GlaxoSmithKline Trading Services Limited

GlaxoSmithKline Pharmaceuticals S.A.

Seroxat

tbl. 30x20 mg

0,64

0,68

19,29

20,25

R

N06AX27 761

DS

esketaminNN507

8 mg

492,35

516,97

N

Janssen-Cilag International N.V.

Janssen Pharmaceutica NV

Spravato

sprej za nos, 1x28 mg

1.723,22

1.809,38

1.723,22

1.809,38

 

R03AC12 763

 

salmeterol

0,1 mg

4,60

4,83

I

GlaxoSmithKline Trading Services Limited

Glaxo Wellcome Production

Serevent inhaler

stlač. inhalat, susp., 120x25 mcg

1,15

1,21

138,00

144,90

R

R03AK06 361

 

salmeterol + flutikazon

 

 

 

I

GlaxoSmithKline Trading Services Limited

Glaxo Wellcome Production, Glaxo Operations UK Ltd.

Seretide 100 Diskus

praš. za inhal. 60x(50+100 mcg)/doza

1,86

1,96

111,72

117,31

RRR02

R03AK06 362

 

salmeterol + flutikazon

 

 

 

I

GlaxoSmithKline Trading Services Limited

Glaxo Wellcome Production, Glaxo Operations UK Ltd.

Seretide 250 Diskus

praš. za inhal. 60x(50+250 mcg)/doza

2,42

2,54

144,90

152,15

RRR02

R03AK06 363

 

salmeterol + flutikazon

 

 

 

I

GlaxoSmithKline Trading Services Limited

Glaxo Wellcome Production, Glaxo Operations UK Ltd.

Seretide 500 Diskus

praš. za inhal. 60x(50+500 mcg)/doza

3,18

3,34

190,68

200,21

RRR03

R03BA05 773

 

flutikazon

0,6 mg

6,12

6,43

I

GlaxoSmithKline Trading Services Limited

Glaxo Wellcome Production, GlaxoWellcome S.A.

Flixotide inhaler

stlač. inhalat, susp. 120x50 mcg

0,51

0,54

61,20

64,26

RRR07

 

 

 

 

«.

Dodaju se nove šifre anatomsko-terapijsko-kemijske (ATK) klasifikacije lijekova Svjetske zdravstvene organizacije, sa sljedećim podacima:

»

 

Šifra ATK

Oznaka

Nezaštićeno ime lijeka

DDD i jed. mj.

Cijena za DDD

Cijena za DDD (s PDV-om)

Način primjene

Nositelj odobrenja

Proizvođač

Zaštićeno ime lijeka

Oblik, jačina i pakiranje lijeka

Cijena jed. oblika

Cijena jed. oblika (s PDV-om)

Cijena orig. pakiranja

Cijena orig. pakiranja (s PDV-om)

R/RS

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

B05AA01 964

DS

ljudski albumin 20%NB502

 

 

 

P

Jana Pharm d.o.o.

Octapharma

Albunorm 20% (HR)

otop. za inf., boč. stakl. 1x100 ml

326,87

343,21

326,87

343,21

 

J01DD01 061

DS

cefotaksimNJ101

4 g

87,44

91,81

P

Apta Medica International d.o.o.

ACS Dobfar S.p.A.

Cefotaksim AptaPharma

praš. za otop. za inj/inf., boč. 10x1 g

21,86

22,95

218,60

229,53

 

J01DD01 062

DS

cefotaksimNJ101

4 g

87,28

91,65

P

Apta Medica International d.o.o.

ACS Dobfar S.p.A.

Cefotaksim AptaPharma

praš. za otop. za inj/inf., boč. 10x2 g

43,64

45,82

436,41

458,23

 

J01DH02 085

DS

meropenemNJ101

3 g

250,26

262,77

P

Ligula Pharma d.o.o.

Venus Pharma GmbH

Meropenem Ligula Pharma

praš. za otop. za inj. ili inf., boč. 10x500 mg

41,71

43,80

417,10

437,96

 

J01DH02 086

DS

meropenemNJ101

3 g

228,42

239,84

P

Ligula Pharma d.o.o.

Venus Pharma GmbH

Meropenem Ligula Pharma

praš. za otop. za inj. ili inf., boč. 10x1000 mg

76,14

79,95

761,40

799,47

 

J01XA01 083

DS

vankomicinNJ101

2 g

91,20

95,76

P

Apta Medica International d.o.o.

Laboratorio Reig Jofre S.A.

Vankomicin AptaPharma

praš. za otop. za inf., boč. 10x500 mg

22,80

23,94

228,00

239,40

 

J01XA01 084

DS

vankomicinNJ101

2 g

84,66

88,90

P

Apta Medica International d.o.o.

Laboratorio Reig Jofre S.A.

Vankomicin AptaPharma

praš. za otop. za inf., boč. 10x1000 mg

42,33

44,45

423,32

444,49

 

L01BA04 045

DS

pemetreksedNL102

 

 

 

P

Accord Healthcare S.L.U.

Accord Healthcare Limited, Wessling Hungary Kft

Pemetrexed Accord

konc. za otop. za inf., boč. 1x1000 mg

5.828,35

6.119,77

5.828,35

6.119,77

 

L01XK04 161

DS

talazoparibNL530

 

 

 

O

Pfizer Europe MA EEIG

Excella GmbH & Co. KG

Talzenna

caps. 30x0,25 mg

450,87

473,41

13.526,10

14.202,41

 

L01XK04 162

DS

talazoparibNL530

 

 

 

O

Pfizer Europe MA EEIG

Excella GmbH & Co. KG

Talzenna

caps. 30x1 mg

1.341,08

1.408,13

40.232,40

42.244,02

 

V06DX03 492

 

namirnice za enteralnu primjenu

 

 

 

O

G-M Pharma Zagreb d.o.o.

Nutricia

Nutridrink Compact Protein

boca 4x125 ml

16,25

17,06

65,00

68,25

RSVS04a

 

 

«.

Brišu se šifre anatomsko-terapijsko-kemijske (ATK) klasifikacije lijekova Svjetske zdravstvene organizacije, sa sljedećim podacima:

»

 

Šifra ATK

Oznaka

Nezaštićeno ime lijeka

DDD i jed. mj.

Cijena za DDD

Cijena za DDD (s PDV-om)

Način primjene

Nositelj odobrenja

Proizvođač

Zaštićeno ime lijeka

Oblik, jačina i pakiranje lijeka

Cijena jed. oblika

Cijena jed. oblika (s PDV-om)

Cijena orig. pakiranja

Cijena orig. pakiranja (s PDV-om)

R/RS

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

A04AA05 081

DS

palonosetronNA402

0,25 mg

238,59

250,52

P

Alvogen Pharma Trading Europe EOOD

Haupt Pharma Wolfrathausen GmbH

Palonozetron Alvogen

otop. za inj., boč. 1x250 mcg/5 ml

238,59

250,52

238,59

250,52

 

C07AB07 143

 

bisoprolol

10 mg

0,83

0,87

O

Jadran - Galenski Laboratorij d.d.

JGL d.d.

Lybrol

tbl. 30x3,75 mg

0,31

0,33

9,32

9,79

R

C08CA05 131

 

nifedipin srednje dugodjelujući

30 mg

0,71

0,74

O

KRKA-FARMA d.o.o.

Krka d.d.

Cordipin R

tbl. 30x20 mg

0,47

0,49

14,11

14,82

R

J05AP01 171

DS

ribavirin

1 g

81,48

85,56

O

Roche d.o.o.

Roche

Copegus

tbl. film obl. 42x200 mg

16,30

17,11

684,46

718,68

 

L01BA01 005

DS

metotreksat

 

 

 

P

Zentiva k.s.

Pliva Hrvatska d.o.o.

Metotreksat Zentiva

otop. za inj., boč. stakl. 1x5 mg/2 ml (2,5 mg/1 ml)

12,79

13,43

12,79

13,43

 

L01EA01 172

DS

imatinibNL115

 

 

 

O

Novartis Europharm Limited Irska

Novartis Pharma

Glivec

tbl. film obl. 60x100 mg

54,57

57,30

3.274,20

3.437,91

 

L02AB01 171

 

megestrol-acetat

0,16 g

8,11

8,51

O

PharmaSwiss Česka republika s.r.o

Polfarmex S.A.

Megoxi

susp. za oral. primj. 1x240 ml (40 mg/ml)

486,50

510,83

486,50

510,83

RSRL22

N05AX08 113

 

risperidon

5 mg

4,92

5,16

O

Belupo d.d.

Belupo

Prospera

tbl. film obl. 60x3 mg

2,95

3,10

177,00

185,85

RSRN06

N05AX08 114

 

risperidon

5 mg

6,57

6,90

O

Belupo d.d.

Belupo

Prospera

tbl. film obl. 60x4 mg

5,26

5,52

315,40

331,17

RSRN06

 

 

 

«.

Dodaje se nova indikacija pod oznakom: »NL530« koja glasi:

»NL530: Monoterapija za liječenje odraslih bolesnika sa zametnim mutacijama gena BRCA1 i BRCA2 koji boluju od lokalno uznapredovalog ili metastatskog trostruko-negativnog raka dojke. Bolesnici su prethodno trebali biti liječeni antraciklinom i/ili taksanom u (neo)adjuvantnom, lokalno uznapredovalom ili metastatskom okruženju osim ako ta liječenja nisu bila prikladna za bolesnike. Nastavak liječenja moguć je isključivo kod pozitivnog tumorskog odgovora na provedeno liječenje (kompletna remisija, parcijalna remisija ili stabilna bolest) uz obveznu prvu procjenu terapijskog učinka liječenja nakon 3 ciklusa liječenja. Svaka sljedeća procjena se radi nakon provedenih 3 ciklusa liječenja. Liječenje odobrava Bolničko povjerenstvo za lijekova na prijedlog internističkog onkologa ili specijalista radioterapije i onkologije.«.

Članak 2.

Ova Odluka objavljuje se u »Narodnim novinama«, a stupa na snagu 1. veljače 2022. godine.

Klasa: 025-04/22-01/02

Urbroj: 338-01-01-22-01

Zagreb, 11. siječnja 2022.

Predsjednik Upravnog vijeća Hrvatskog zavoda za zdravstveno osiguranje prof. dr. sc. Drago Prgomet, dr. med. spec., v. r.

 

 

 

Izvor: https://narodne-novine.nn.hr/clanci/sluzbeni/2022_01_6_57.html

Copyright © Ante Borić